Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
MOMobia Medical, Inc. logo

Mobia Medical, Inc. (MOBI)

NASDAQ Global Select · Currency in USD
$10.41 ▼ -0.17 (-1.61%)
At close: Oct 23, 4:00 PM ET. Market closed.
$10.45 ▲ +0.04 (+0.38%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$10.58
Open
$10.60
Day's Range
$10.25 – $10.60
52 Week Range
$8.03 – $15.29
Volume
267,064
Avg. Volume
173,190
Market Cap
$346.56M
Beta (5Y Monthly)
-0.59
PE Ratio (TTM)
--
EPS (TTM)
-$2.03
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$25.00

Profile: Mobia Medical, Inc.

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
167
CEO
Richard Foust
Website
mobia.com

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.46 · Revenue est. $14.04M
DateEst.Actual
Aug 11, 2026-$0.71-$1.10Miss
Jun 4, 2026-$18.79-$0.53Beat

Analyst view

Consensus price target
$25.00 ▲ +140.2%
Range $19.00 – $31.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on MOBI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.